Success! You're on the list.

Success! You're on the list.

UK deep tech Siloton eyes £1M for its at-home AMD diagnostic imaging device

Siloton founders
Picture credits: Siloton

Macular disease is increasingly becoming the biggest cause of eyesight loss in the UK. Age-related macular degeneration (AMD) is an eye disease that can get worse with time. It’s the leading cause of severe vision loss in people aged 60 and above. Bristol-based deep tech Siloton is developing an at-home monitoring service for 25% of those over 60 with AMD. 

Now, Siloton, which plans to raise £1 million in seed funding, has closed £190K led by South East Angels. The investment will fuel the development and deployment of Siloton’s core product – an at-home monitoring service, and help realise its potential to save the NHS half a billion pounds each year. This follows the £470K investment it secured last year. 

Uses photonic chip technology

Siloton was founded in 2020 in Bristol by Euan Allen, Ben Hunt, and Alasdair Price. It was an alumnus of the Quantum Technologies Enterprise Centre (QTEC) incubator programme. Its at-home diagnostic imaging device is touted to reduce the burden of treatment, alleviating pressure on healthcare systems, while helping patients retain their sight for longer.

Siloton’s product combines next-gen hardware with cloud-based digital health tools, enabling clinicians to deliver an unparalleled quality of care to their patients. At the core of the technology is a photonic integrated circuit (PIC), allowing it to compress large, expensive, and fragile optical components onto a single piece of material smaller than a £1 coin.

Commenting on this round, Kristina Pereckaite, Managing Director of South East Angels, said: This company sits at the heart of what our group cares about most: creating positive impact, investing in cutting-edge technology, and backing exceptional founders. We’re pleased to have our group leading this round to help propel the company through its next stage of development. We are excited about the positive impact Siloton’s technology will have on the health of individuals globally and its ability to make a meaningful difference in healthcare”

Dr. Alasdair Price, CEO of Siloton, added: “South East Angels are a highly-motivated group of investors, whose focus on positive impact through cutting-edge technology makes them the perfect match for Siloton. We’re delighted to have them on board and are excited to be working with them going forward.”

Related Posts

Get daily funding news briefings in the tech world delivered right to your inbox.

Enter Your Email
join our newsletter. thank you